Health Idea Now
Friday, 12 April 2019
Clovis Oncology halts mid-stage bladder cancer trial, shares drop
Clovis Oncology Inc said on Friday it was halting a mid-stage trial testing its lead drug in bladder cancer patients, sending shares down 12 percent.
from Reuters: Health News https://reut.rs/2P9CHD5
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment